Imricor Medical Systems Inc
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include… Read more
Imricor Medical Systems Inc (IMR) - Total Liabilities
Latest total liabilities as of June 2025: AU$32.49 Million AUD
Based on the latest financial reports, Imricor Medical Systems Inc (IMR) has total liabilities worth AU$32.49 Million AUD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Imricor Medical Systems Inc - Total Liabilities Trend (2016–2024)
This chart illustrates how Imricor Medical Systems Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Imricor Medical Systems Inc Competitors by Total Liabilities
The table below lists competitors of Imricor Medical Systems Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Strong Biotechnologies Inc
SHE:300406
|
China | CN¥1.30 Billion |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
|
China | CN¥1.19 Billion |
|
Berli Jucker PCL
BK:BJC
|
Thailand | ฿205.81 Billion |
|
Wuhan Sanzhen Industry Holding Co Ltd
SHG:600168
|
China | CN¥18.85 Billion |
|
Kumyang
KO:001570
|
Korea | ₩750.35 Billion |
|
Keystone Microtech Corp
TWO:6683
|
Taiwan | NT$553.77 Million |
|
World Acceptance Corporation
NASDAQ:WRLD
|
USA | $790.78 Million |
|
Shanghai Information2 Software Inc. A
SHG:688435
|
China | CN¥68.22 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Imricor Medical Systems Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 26.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Imricor Medical Systems Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Imricor Medical Systems Inc (2016–2024)
The table below shows the annual total liabilities of Imricor Medical Systems Inc from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$29.00 Million | +69.98% |
| 2023-12-31 | AU$17.06 Million | +175.61% |
| 2022-12-31 | AU$6.19 Million | +38.68% |
| 2021-12-31 | AU$4.46 Million | -6.09% |
| 2020-12-31 | AU$4.75 Million | +36.27% |
| 2019-12-31 | AU$3.49 Million | +34.78% |
| 2018-12-31 | AU$2.59 Million | -68.63% |
| 2017-12-31 | AU$8.25 Million | +10.08% |
| 2016-12-31 | AU$7.50 Million | -- |